disease-research

Integrate ENCODE regulatory elements and GWAS data to interpret non-coding disease variants.

26|5|Updated Mar 8, 2026

Search Tags:#genomics #disease #GWAS #clinical #epigenomics #regulatory elements #functional annotation

Ready to run

npx skills add https://github.com/ammawla/encode-toolkit --skill disease-research

💬 Prompt for ChatGPT / Claude Chat▼

Please help me install this Agent Skill.
Skill: disease-research
Source: https://github.com/ammawla/encode-toolkit/tree/main/plugin/skills/disease-research
Command: npx skills add https://github.com/ammawla/encode-toolkit --skill disease-research

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill includes scripts (resource) and references (resource) components.

What problem does it solve?

This Skill helps researchers interpret non-coding disease-associated variants by linking GWAS findings to ENCODE functional genomics data, revealing underlying regulatory mechanisms.

Core Features & Use Cases

Connects GWAS variants to regulatory elements in disease-relevant tissues, facilitating candidate gene identification.
Integrates ENCODE with clinical and pharmacological databases to identify therapeutic targets and relevant clinical trials.
Builds comprehensive disease models by combining chromatin state, TF binding, enhancer linking, and expression data to elucidate disease pathways.
Use case: A researcher investigating Alzheimer's disease can identify non-coding risk variants in brain enhancers and prioritize candidate genes for further validation.

Quick Start

Input disease-specific GWAS variants and request an integrated analysis of ENCODE regulatory annotations in disease-relevant tissues.

Frequently Asked Questions about disease-research

High-intent search queries and answers about installing and using this skill.

FAQPage Schema

How do I interpret non-coding variants from GWAS using ENCODE data?▼

To interpret non-coding variants, this analysis integrates ENCODE regulatory elements with GWAS data to link findings to functional genomics, revealing underlying disease mechanisms. It connects variants to disease-relevant tissues for candidate gene identification.

What is the best way to connect GWAS variants to regulatory elements in disease tissues?▼

The best way to connect GWAS variants to regulatory elements is by integrating ENCODE epigenomic data and target linkage models. This approach maps non-coding risk variants to chromatin states and enhancers in specific disease tissues.

Can I identify therapeutic targets by integrating ENCODE with clinical databases?▼

Yes, you can identify therapeutic targets by integrating ENCODE functional genomics with clinical and pharmacological databases. This process highlights relevant clinical trials and potential treatments based on disease pathways.

Do I need target linkage models for comprehensive disease model building?▼

Yes, target linkage models are required alongside ENCODE epigenomic data and GWAS catalogs for comprehensive analysis. They enable the combination of chromatin state, TF binding, enhancer linking, and expression data to elucidate pathways.

How does integrating chromatin state and enhancer linking elucidate disease pathways?▼

Integrating chromatin state, TF binding, enhancer linking, and expression data elucidates disease pathways by building comprehensive models. These models reveal how non-coding variants disrupt regulatory mechanisms in disease-relevant tissues.

How do I prioritize candidate genes for Alzheimer's disease using functional annotation?▼

To prioritize candidate genes for Alzheimer's disease, input disease-specific GWAS variants to request an integrated analysis of ENCODE regulatory annotations. This identifies non-coding risk variants in brain enhancers for further validation.